Table 1 TCGA binary tasks
Project | Disease | Label | Label type | Group | Samples |
|---|---|---|---|---|---|
TCGA stage tasks | |||||
COAD | colon adenocarcinoma | II- vs. III+ | binary | train | 505 |
KIRC | kidney renal clear cell carcinoma | II- vs. III+ | binary | train | 544 |
LIHC | liver hepatocellular carcinoma | I- vs. II+ | binary | train | 374 |
LUAD | lung adenocarcinoma | I- vs. II+ | binary | train | 542 |
SKCM | skin cutaneous melanoma | II- vs. III+ | binary | train | 249 |
STAD | stomach adenocarcinoma | II- vs. III+ | binary | train | 416 |
THCA | thyroid cancer | I- vs. II+ | binary | train | 513 |
UCEC | uterine corpus endometrial carcinoma | I- vs. II+ | binary | train | 554 |
LUSC | lung squamous cell carcinoma | I- vs. II+ | binary | validate | 504 |
BRCA | breast invasive carcinoma | II- vs. III+ | binary | test | 1134 |
TCGA grade tasks | |||||
CESC | cervical squamous cell carcinoma | II- vs. III+ | binary | train | 306 |
KIRC | kidney renal clear cell carcinoma | II- vs. III+ | binary | train | 544 |
LGG | low grade glioma | II- vs. III+ | binary | train | 532 |
LIHC | liver hepatocellular carcinoma | II- vs. III+ | binary | train | 374 |
PAAD | pancreatic adenocarcinoma | II- vs. III+ | binary | train | 179 |
STAD | stomach adenocarcinoma | II- vs. III+ | binary | train | 416 |
UCEC | uterine corpus endometrial carcinoma | II- vs. III+ | binary | train | 554 |
HNSC | head-neck squamous cell carcinoma | II- vs. III+ | binary | test | 504 |